Sign In
close X
The user name and password you entered does not match
the information we have on file.
Forgot your password?
Contact us
close X
Please enter a valid code.
Contact us
Home
|
Texts
|
Drugs
|
Images
|
Guidelines
|
Patient Education
Showing Results for
papillary thyroid carcinoma
Narrow Results
Topics
All Topics (12)
familial (1)
genetics (1)
imaging studies (1)
mortality (1)
Content Types
All (12)
Texts (10)
Images (2)
NCI Clinical Trials
Looking for trials?
Go to NCI and browse 8,000+ trials
12
Search Results
View in context
View in context
Cancer: Principles & Practice of Oncology
Chapter 107. Molecular Biology of Endocrine Tumors >
Papillary Thyroid Carcinoma
Malignant tumors of the thyroid gland have a great range of biological behavior, ranging from the slow growing to highly aggressive. Over the past two decades the genetic mutations and ...
Perez and Brady’s Principles and Practice of Radiation Oncology
Chapter 47. Thyroid >
Papillary and Mixed Papillary-Follicular Cancers
Despite the differences in their histologic patterns, papillary and mixed papillary-follicular cancers are considered to represent a spectrum of neoplasms because they show biologic and clinicopathologic similarities. These neoplasms, representing ...
Principles and Practice of Surgical Oncology
Chapter 50. Diagnosis and Management of Thyroid Cancer >
Papillary Thyroid Cancer
Papillary thyroid cancer (PTC) accounts for 80% of all thyroid cancer cases. PTC has a peak incidence in the third decade of life and has a 2:1 female to male ...
Principles of Molecular Diagnostics and Personalized Cancer Medicine
Chapter 33. Molecular Diagnostics of Head and Neck Cancer >
Papillary Thyroid Carcinoma
Papillary carcinoma is the most common of all thyroid carcinomas, accounting for more than 70% of these tumors. They may present at any age with peak incidence between 30 and ...
Principles of Molecular Diagnostics and Personalized Cancer Medicine
Chapter 33. Molecular Diagnostics of Head and Neck Cancer >
Papillary Thyroid Carcinoma
Frequent alterations at the BRAF and the RAS genes and RET/PTC rearrangement are found in PTC. These alterations are in large part mutually exclusive and lead to the activation of ...
Cancer: Principles & Practice of Oncology
Chapter 108. Thyroid Tumors > Thyroid Tumor Classification and Staging Systems
Within the category of well-differentiated thyroid cancers various histologic subtypes ...
Cancer: Principles & Practice of Oncology
Chapter 108. Thyroid Tumors > Pathology
Papillary thyroid carcinoma constitutes approximately 80% to 85% of malignant ...
Cancer: Principles & Practice of Oncology
Chapter 108. Thyroid Tumors > Natural History and Prognosis
Regional lymph node metastases are present at the time of ...
Principles and Practice of Surgical Oncology
Chapter 50. Diagnosis and Management of Thyroid Cancer > Presentation
The most common nonmedullary familial thyroid cancer, familial PTC accounts ...
Principles and Practice of Surgical Oncology
Chapter 50. Diagnosis and Management of Thyroid Cancer > Does Size Matter?
The mortality rate following therapy for papillary thyroid microcarcinomas is ...
Didn't find what you were looking for?
Run a full-text search on 'papillary thyroid carcinoma'
What do you think of LWWOncology?
Share Your Feedback
More Results
Journal Results from PubMed
Randomized controlled trial of a computerized decision aid on adjuvant radioactive iodine treatment for patients with early-stage papillary thyroid cancer.
J. Clin. Oncol. | Aug 9, 2012
Strategies of radioiodine ablation in patients with low-risk thyroid cancer.
N. Engl. J. Med. | May 3, 2012
A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic.
Oncogene | Oct 11, 2012
MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
Oncogene | Apr 12, 2012
Good clinical response to erlotinib in a patient with anaplastic thyroid carcinoma harboring an epidermal growth factor somatic mutation, L858R, in exon 21.
J. Clin. Oncol. | May 30, 2011
View More on PubMed
>